Infants with cryptogenic infantile spasms seem to differ from those with symptomatic spasms in having a higher cerebrospinal fluid corticotropin content, different levels of corticotropin release after exogenous vasopressin, higher serum levels of progesterone, higher dehydroepiandrosterone:androstenedione ratio (during corticotropin therapy), a higher cerebrospinal fluid γ-aminobutyric acid content, and higher cerebrospinal fluid nerve growth factor concentrations. It remains to be seen whether the biochemical differences between the two groups are specific or only happen to correlate with the early brain damage. However, these differences would explain many pathophysiologic features of infantile spasms. (J Child Neurol 1996; 11: 383-388).
Get full access to this article
View all access options for this article.
References
1.
Commission on Pediatric Epilepsy of the International League Against Epilepsy: Workshop on infantile spasms. Epilepsia1992; 33:195.
2.
Riikonen R., Simell O.: Tuberous sclerosis and infantile spasms. Dev Med Child Neurol1990;32:203-209.
3.
Riikonen R.: Decreasing perinatal mortality: Unchanged infantile spasm morbidity . Dev Med Child Neurol1995;37: 198-204.
4.
Riikonen R.: Infantile spasms: Infectious disorders. Neuropediatrics1993;24:274-280.
5.
Riikonen R., Gupta D.: Effect of ACTH treatment on CSF ACTH, IgG index and serum: CSF albumin ratio in children with infantile spasms: Preliminary observation. Neuroendocrinol Lett1988;10:355-361.
6.
Riikonen R., Simell O., Dunkel L., et al: Hormonal background of the hypertension and fluid derangements associated with adrenocorticotropic hormone of infants. Eur J Pediatr1989;148:737-741.
7.
Perheentupa J. , Riikonen R., Dunkel L., Simell O.: Adrenocortical hyporesponsiveness after treatment with ACTH of infantile spasms. Arch Dis Child1986;61:750-753.
8.
Riikonen R., Perheentupa J.: Serum steroids and success of corticotropin therapy. Acta Pediatr Scand1986;75:598-600.
9.
Airaksinen E. , Tuomisto L., Riikonen R.: The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment. Brain Dev1992;14:386-390.
10.
Landon J., James V., Stoker D.: Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function. Lancet1965;2:1156-1159.
11.
Holmes G.: Effect of non-sex hormones on neuronal excitability, seizures, and electroencephalogram . Epilepsia1991;5(Suppl): S11-S18.
12.
Belelli D., Lan N., Gee K.: Anticonvulsant steroids and GABA/ benzodiazepine receptor-chloride ionophore complex. Neurosci Behav Rev1990 ;14:315-322.
13.
Lan N., Bolger M., Gee W.: Identification and characterization of a pregnane steroid recognition site that is functionally coupled to an expressed GABAA receptor. Neurochem Res1991;6:347-356.
14.
Purdy R., Moore P., Rao P., et al: Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids1990; 55:290-296.
15.
Taubøll E., Gjerstad L.: Comparison of 5α-pregnan-3α-ol-20-one and phenobarbital on cortical synaptic activation and inhibition studied in vitro. Epilepsia1993;34:228-235.
16.
Taubøll E., Lindström S.: The effect of progesterone and its metabolite 5α-pregnan-3α-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo. Epilepsy Res1993;14:17-30.
17.
Eneroth P., Gustafsson J., Ferngren H., Hellström B.: Excretion and anticonvulsant activity of steroid hormones in an infant with infantile spasms, and hypsarrhythmia treated with excessive doses of ACTH . J Steroid Biochem1972;3:877-887.
18.
Lindholm D. , Hengerer B., Castren E.: In vitro and in vivo methods for evaluating actions of cytokines on nerve growth factor production in central nervous system. Methods Neurosci1993;17: 37-60.
19.
Tabarin F., San Galli F., Dezou S., et al: The corticotrophin-releasing factor test in the differential diagnosis of Cushing's syndrome: A comparison with the lysine-vasopressin test. Acta Endocrinol1990;123:331-338.
20.
Baram T.: Pathophysiology of massive infantile spasms: Perspective on the putative role of the brain-adrenal axis. Ann Neurol1993 ; 33:231-236.
21.
Riikonen R. : Infantile spasms: Some new theoretical aspects . Epilepsia1983;24:159-168.
22.
Hrachovy R., Frost J.: Infantile spasms: A disorder of the developing nervous system, in Kellaway P, Noebels J (eds): Problems and Concepts in Developing Neurophysiology . Baltimore, Johns Hopkins University Press, 1989, pp 131-147.
23.
Nalin A., Facchinetti F., Galli V., et al: Reduced ACTH content in CSF of children affected by infantile spasms and hypsarrhythmia. Epilepsia1985;26:446-449.
24.
Bajorek J., Lee R., Lomax P.: Neuropeptides: Anticonvulsant and convulsant mechanisms in epileptic model systems and in humans. Adv Neurol1986 ;44:489-500.
25.
Baram T., Mitchell W., Snead O. III, et al: Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology1992 ;42:1171-1175.
26.
Mangili G., Motta M., Martini L.: Adrenocorticotrophic hormone secretion, in Martini L, Gannong W (eds): Neuroendocrinology, vol 1. New York, Academic Press, 1966, pp 298-370.
27.
McDonald J. , Johnston M.: Physiological and pathophysiological roles of excitatory amino acids during central nervous system development . Brain Res Rev1990;15:41-70.
28.
Spink D., Snead O., Swann J., Martin D.: Free amino acids in cerebrospinal fluid from patients with infantile spasms . Epilepsia1988;29:300-306.
29.
Gillies G., Linton E., Lowry P.: The physiology of corticotrophin-releasing factor, in DeGroot L (ed): Endocrinology. Philadelphia, WB Saunders, 1989 , pp 167-175.
30.
Salata R., Jarrett D., Verbalis J., Robinson G.: Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans . In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest1988;81:766-774.
31.
Huttenlocher P.: Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology1974;24: 203-210.
32.
Jones M., Hillhouse E., Burden J.: The effect of various putative neurotransmitters on the release of CRF from the rat hypothalamus in vitro. J Endocrinol1976;69:1-10.
33.
Holmes G., Weber D.: Effects of ACTH on seizure susceptibility in the developing brain . Ann Neurol1986;20:82-88.
34.
Levi-Montalchini R.: The nerve growth factor 35 years later. Science1987;23:1154-1161.
35.
Sofroniew M. , Cooper J.: Neurotrophic mechanisms and neuronal degeneration . Neuroscience1993;5:285-294.
36.
Hrachovy R. , Frost J.: Infantile spasms. Pediatr CLin North Am1989; 36:318.
37.
Pranzatelli M.: Putative neurotransmitter abnormalities in infantile spasms: Cerebrospinal fluid neurochemistry and drug effects. J Child Neurol1994;9:119-129.
38.
Mattson M., Murrain M., Kater S.: Fibroblast growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal neuroarchitectures. J Neurosci1989;9:3728-3740.
39.
Lipton S., Rosenberg P.: Excitatory amino acids as a fmal common pathway for neurologic disorders . N Engl J Med1994;330:618-622.
40.
Hattori H., Wasterlain C.: Excitatory amino acids in the developing brain: Ontogeny, plasticity, and excitotoxity. Pediatr Neurol1990;6:219-228.
